Synchron
The brain-computer interface device powering autonomy
New York, United States · Founded 2016 · $325.0M raised
- Headquarters
- New York, New York
- Employees
- 51–200
- Founded
- 2016
- Business Model
- B2B
- Website
- synchron.com
- Total Funding
- $325.0M
- Last Round
- $200.0M Series DNov 2025
- Rounds
- 4
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Synchron is developing a minimally invasive brain-computer interface (BCI) called Stentrode, implanted via endovascular procedure without open brain surgery. It enables people with paralysis to control digital devices using thoughts, restoring autonomy and addressing unmet medical needs in neurology.
Summary
Synchron is a Biotech company based in New York, United States, founded in 2016. It has raised $325.0M in total across 4 rounds, most recently a $200.0M Series D round in Nov 2025. Investors include Khosla Ventures, Double Point Ventures and ARCH Venture Partners.
Tech & App Stack
6 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Nov 2025
Sign up to see all 4 events
Funding: Series A through Series D. Amounts, valuations, and investors where available.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Integrated biopharmaceutical solutions company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/synchron"><img src="https://indexed.vc/api/badge/company/synchron" alt="Synchron on Indexed.vc" width="260" height="76" /></a>